CALL/AMGEN/500/0.1/20.09.24 Share Price

DE000GG2YK96

Real-time BOERSE MUENCHEN 17:26:03 21/05/2024 BST
0.026 ^EUR	+4.00%

Current month	+66.67%
1 month	+78.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Amgen : Actress and Producer Gina Torres Urges Hispanic Americans to Prioritize Cholesterol Care	04:55pm	PU
Amgen : At Milken Global Conference, Bradway Calls for Protecting U.S. Policy Ecosystem That Fosters Innovation	05-20	PU
Driving Long-Term Growth: IMDELLTRA™ Approval and Information Update Presentation	05-20	PU
Transcript : Amgen Inc. - Special Call	05-20

More news

Quotes 5-day view

Date	Price	Change
21/05/24	0.026	+4.00%
20/05/24	0.025	-10.71%
17/05/24	0.028	+3.70%
16/05/24	0.027	+17.39%
15/05/24	0.023	+9.52%

Real-time BOERSE MUENCHEN

Last update May 21, 2024 at 05:26 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Goldman Sachs
WKN	GG2YK9
ISIN	DE000GG2YK96
Date issued	30/01/2024
Strike	500 $
Maturity	20/09/2024 (122 Days)
Parity	10 : 1
Emission price	0.02 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.048 €
Lowest since issue	0.007 €
Spread	0.1 €
Spread %	76.92%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

314.5 USD

Average target price

316.1 USD

Spread / Average Target

+0.48%

Consensus